Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced Salt Solution for dry eye in mechanically ventilated ICU patients
IRCT20200113046121N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of balance salt solution and artificial tears in dry eye syndrome (DED) (2 arms), sponsored by Lorestan University of Medical Sciences. Primary endpoints: Dry eye, Schirmer test and 1 more. Started Jul 2019; status: completed.
02
Drugs
balance salt solutionartificial tears
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on IRCT20200113046121N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200113046121N1.